HIGHLIGHTS
- who: Kei Takayama and colleagues from the Ophthalmology, Hyogo College of Medicine, Nishinomiya, Japan, Department of Ophthalmology have published the Article: Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy, in the Journal: PLOS ONE of September/27,/2021
- what: The authors investigated factors related to the potential bias of retinal surgeons in using IVI prior to vitrectomy for PDR-related complications and evaluated the real-world outcomes of surgeon-determined preoperative IVI. In the present study, younger age, shorter diabetes treatment duration, higher frequencies of preoperative NVG and TRD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.